Physician profile
Ken E Mishler
NPI 1043279979
$198.81
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $28.07 · 2021: $59.10.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $60.42 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $41.35 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $40.36 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $14.67 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $14.58 | 2019 | |
| Aerie Pharmaceuticals, INC. | $14.40 | 2020 | |
| Shire North American Group INC | $13.03 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ken Mishler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.